Phase 1 clinical trials are the first step in testing new drugs or treatments on humans. These trials are conducted to evaluate the safety and dosage of a potential treatment, as well as to identify any potential side effects. Participants in phase 1 trials are closely monitored, and researchers collect data on how the treatment is metabolized and its overall impact on the body. This information is crucial in determining the next steps in the drug development process. If you are considering participating in a phase 1 clinical trial, it is important to consult with your healthcare provider to fully understand the potential risks and benefits.